Health
Novartis Cardiovascular Drug Fails Pivotal Study
Novartis' experimental cardiovascular drug failed in a pivotal study, marking a significant setback for the company. The failure comes as the firm faces increasing pressure to deliver results.
Coverage timeline — 1 article
STAT News
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.
2026-09-04 21:07 UTC